Leah Croll, MD, Assistant Professor of Clinical Neurology at the Lewis Katz School of Medicine at Temple University, offered insight to NBC10 about Leqembi, which has been granted full approval by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease. The drug is indicated for those with mild cognitive impairment or the mild dementia stage of Alzheimer’s.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH